Palatin Technologies, Inc. - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 42 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Palatin Technologies, Inc. - Product Pipeline Review - 2014" provides data on the Palatin Technologies, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Palatin Technologies, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Palatin Technologies, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Palatin Technologies, Inc. - Brief Palatin Technologies, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Palatin Technologies, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Palatin Technologies, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Palatin Technologies, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Palatin Technologies, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Palatin Technologies, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Palatin Technologies, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Palatin Technologies, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Palatin Technologies, Inc. and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Palatin Technologies, Inc. Snapshot 5
Palatin Technologies, Inc. Overview 5
Key Information 5
Key Facts 5
Palatin Technologies, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Palatin Technologies, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Palatin Technologies, Inc. - Pipeline Products Glance 11
Palatin Technologies, Inc. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Palatin Technologies, Inc. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Palatin Technologies, Inc. - Unknown Stage Pipeline Products 14
Unknown Products/Combination Treatment Modalities 14
Palatin Technologies, Inc. - Drug Profiles 15
bremelanotide 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
PL-3994 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Melanocortin Receptor-1 Peptides 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
PL-6983 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Drug For Cachexia 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Next Generation Melanocortin Receptor Specific Peptide 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Palatin Technologies, Inc. - Pipeline Analysis 23
Palatin Technologies, Inc. - Pipeline Products by Therapeutic Class 23
Palatin Technologies, Inc. - Pipeline Products by Target 25
Palatin Technologies, Inc. - Pipeline Products by Route of Administration 27
Palatin Technologies, Inc. - Pipeline Products by Molecule Type 28
Palatin Technologies, Inc. - Pipeline Products by Mechanism of Action 29
Palatin Technologies, Inc. - Recent Pipeline Updates 31
Palatin Technologies, Inc. - Discontinued Pipeline Products 34
Discontinued Pipeline Product Profiles 34
bremelanotide 34
Palatin Technologies, Inc. - Company Statement 35
Palatin Technologies, Inc. - Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Appendix 41
Methodology 41
Coverage 41
Secondary Research 41
Primary Research 41
Expert Panel Validation 41
Contact Us 42
Disclaimer 42

List of Tables
Palatin Technologies, Inc., Key Information 5
Palatin Technologies, Inc., Key Facts 5
Palatin Technologies, Inc. - Pipeline by Indication, 2014 8
Palatin Technologies, Inc. - Pipeline by Stage of Development, 2014 9
Palatin Technologies, Inc. - Monotherapy Products in Pipeline, 2014 10
Palatin Technologies, Inc. - Phase II, 2014 11
Palatin Technologies, Inc. - Preclinical, 2014 12
Palatin Technologies, Inc. - Discovery, 2014 13
Palatin Technologies, Inc. - Unknown, 2014 14
Palatin Technologies, Inc. - Pipeline by Therapeutic Class, 2014 24
Palatin Technologies, Inc. - Pipeline by Target, 2014 26
Palatin Technologies, Inc. - Pipeline by Route of Administration, 2014 27
Palatin Technologies, Inc. - Pipeline by Molecule Type, 2014 28
Palatin Technologies, Inc. - Pipeline Products by Mechanism of Action, 2014 30
Palatin Technologies, Inc. - Recent Pipeline Updates, 2014 31
Palatin Technologies, Inc. - Discontinued Pipeline Products, 2014 34
Palatin Technologies, Inc., Subsidiaries 40